Jonathan M Nugent - Net Worth and Insider Trading
Jonathan M Nugent Net Worth
The estimated net worth of Jonathan M Nugent is at least $3,114 dollars as of 2024-05-27. Jonathan M Nugent is the VP Corp Communications of BioCryst Pharmaceuticals Inc and owns about 508 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $3,114. Details can be seen in Jonathan M Nugent's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jonathan M Nugent has not made any transactions after 2007-07-31 and currently still holds the listed stock(s).
Transaction Summary of Jonathan M Nugent
Jonathan M Nugent Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jonathan M Nugent owns 1 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) .
Click here to see the complete history of Jonathan M Nugent’s form 4 insider trades.
Insider Ownership Summary of Jonathan M Nugent
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2007-07-31 | VP Corp Communications |
Jonathan M Nugent Latest Holdings Summary
Jonathan M Nugent currently owns a total of 1 stock. Jonathan M Nugent owns 508 shares of BioCryst Pharmaceuticals Inc (BCRX) as of July 31, 2007, with a value of $3,114.
Latest Holdings of Jonathan M Nugent
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2007-07-31 | 508 | 6.13 | 3,114 |
Holding Weightings of Jonathan M Nugent
Jonathan M Nugent Form 4 Trading Tracker
According to the SEC Form 4 filings, Jonathan M Nugent has made a total of 0 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years. The most-recent trade in BioCryst Pharmaceuticals Inc is the acquisition of 285 shares on July 31, 2007, which cost Jonathan M Nugent around $2,009.
Insider Trading History of Jonathan M Nugent
- 1
Jonathan M Nugent Trading Performance
GuruFocus tracks the stock performance after each of Jonathan M Nugent's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jonathan M Nugent is -10.8%. GuruFocus also compares Jonathan M Nugent's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jonathan M Nugent within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jonathan M Nugent's insider trading performs compared to the benchmark.
Performance of Jonathan M Nugent
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.93 | | | | | |
| Relative Return to S&P 500(%) | 14.06 | | | | | |
Jonathan M Nugent Ownership Network
Jonathan M Nugent Owned Company Details
What does BioCryst Pharmaceuticals Inc do?
Who are the key executives at BioCryst Pharmaceuticals Inc?
Jonathan M Nugent is the VP Corp Communications of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Chief Financial Officer Anthony Doyle , Vice President and CCO Charles K Gayer , and VP & General Counsel & Corp Sec Alane P Barnes .
BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary
Over the past 18 months, Jonathan M Nugent made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 381,673 shares made by Jon P Stonehouse , a net purchase of 19,875 shares made by Helen M. Thackray , and a net purchase of 30,600 shares made by Anthony Doyle .
In summary, during the past 3 months, insiders sold 0 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 173,240 shares, with a net purchase of 173,240 shares. During the past 18 months, 463,684 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 173,240 shares were bought by its insiders, resulting in a net sale of 290,444 shares.
BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioCryst Pharmaceuticals Inc Insider Transactions
Jonathan M Nugent Mailing Address
Above is the net worth, insider trading, and ownership report for Jonathan M Nugent. You might contact Jonathan M Nugent via mailing address: 2190 Parkway Lake Dr, Birmingham Al 35244.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
